Procter & Gamble Hygiene and Health Care Limited announced that its Board meeting, scheduled for November 6, 2025, will include a review of the unaudited financial results for the quarter ended September 30, 2025. This update follows their previous letter regarding the board meeting. The company has informed the stock exchanges about the revision to the meeting agenda.
Board Meeting Agenda Revised
The Board of Directors of Procter & Gamble Hygiene and Health Care Limited will convene on November 6, 2025. The agenda has been updated to include the approval of the unaudited financial results. This revision follows the company’s earlier communication regarding the scheduled board meeting.
Financial Results Review
During the meeting, the board will consider and approve the unaudited financial results for the quarter ended September 30, 2025 (Q2 FY26). This decision is in line with the company’s commitment to transparent financial reporting.
Source: BSE
